Yuyue Healthcare (002223): Product-driven with potential for continued growth
Yuyue Healthcare (002223): Overall performance growth is steady and continues to expand overseas potential
Yuyue Healthcare (002223): Overseas business sees high potential Yuyue
Yuyue Medical (002223): Steady growth in blood sugar and breathing under a high base, multiple business lines continue to be impressive
Yuyue Medical (002223): Innovation and reshaping growth, leading household device platform gains new vitality
Yuyue Healthcare (002223): Performance growth is in line with expectations and gradually enters a steady growth phase
Yuyue Healthcare (002223): Short-term fluctuations due to base change are optimistic about innovation and overseas driving growth
Yuyue Medical (002223) 2023 Report 2024 Quarterly Report Comment: Performance is in line with expectations, and the blood sugar business is gradually accelerating
Yuyue Healthcare (002223): Product structure optimization, gross margin increased significantly
Yuyue Medical (002223) 2023 Report and 2024 Quarterly Report Review: Performance is in line with expectations, domestic and overseas two-wheel drive
Yuyue Healthcare (002223): Under pressure from a high base, the growth rate is expected to grow steadily throughout the year
Yuyue Healthcare (002223): Steady performance development and continuous cost optimization
Yuyue Medical (002223): Accelerated growth in new product releases can be expected to continue
Yuyue Medical (002223): 1Q profit is under pressure due to high base, optimistic about subsequent recovery
Yuyue Healthcare (002223): The company's overall performance in '23 achieved incentive targets and steady development in major sectors
Yuyue Medical (002223): Formulate a “Double Improvement of Quality and Return” Plan to Promote the Long-term Healthy Development of the Enterprise
Yuyue Medical (002223) Company Comment: Annual performance grew rapidly, and profit levels improved significantly
Yuyue Medical (002223): Continued optimization of profitability, launch of new CGM products, driving rapid growth in diabetes care
Yuyue Medical (002223): Outstanding performance in Double Eleven, new products provide growth impetus
Yuyue Medical (002223): Q3 revenue side temporarily puts pressure on new product iteration and track expansion to lay the foundation for long-term growth
No Data